Dr Salam Consultancy Limited 07194168 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is a Consultant Gastroenterologist practice Digita Accounts Production Advanced 6.30.9574.0 Software true true 07194168 2023-04-01 2024-03-31 07194168 2024-03-31 07194168 bus:Director1 1 2024-03-31 07194168 bus:OrdinaryShareClass1 2024-03-31 07194168 bus:OrdinaryShareClass2 2024-03-31 07194168 core:RetainedEarningsAccumulatedLosses 2024-03-31 07194168 core:ShareCapital 2024-03-31 07194168 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 07194168 core:OfficeEquipment 2024-03-31 07194168 bus:SmallEntities 2023-04-01 2024-03-31 07194168 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 07194168 bus:FullAccounts 2023-04-01 2024-03-31 07194168 bus:RegisteredOffice 2023-04-01 2024-03-31 07194168 bus:Director1 2023-04-01 2024-03-31 07194168 bus:Director1 1 2023-04-01 2024-03-31 07194168 bus:Director2 2023-04-01 2024-03-31 07194168 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 07194168 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 07194168 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 07194168 core:OfficeEquipment 2023-04-01 2024-03-31 07194168 countries:AllCountries 2023-04-01 2024-03-31 07194168 2023-03-31 07194168 bus:Director1 1 2023-03-31 07194168 core:OfficeEquipment 2023-03-31 07194168 2022-04-01 2023-03-31 07194168 2023-03-31 07194168 bus:Director1 1 2023-03-31 07194168 bus:OrdinaryShareClass1 2023-03-31 07194168 bus:OrdinaryShareClass2 2023-03-31 07194168 core:RetainedEarningsAccumulatedLosses 2023-03-31 07194168 core:ShareCapital 2023-03-31 07194168 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 07194168 core:OfficeEquipment 2023-03-31 07194168 bus:Director1 1 2022-04-01 2023-03-31 07194168 bus:Director1 1 2022-03-31 iso4217:GBP xbrli:pure xbrli:shares

Filleted

Registration number: 07194168

Dr Salam Consultancy Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2024

 

Dr Salam Consultancy Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3 to 6

 

Dr Salam Consultancy Limited

Company Information

Directors

Dr I Salam

Mrs E M Salam

Registered office

37 Roper Crescent
Sunbury-on-Thames
TW16 5BA

 

Dr Salam Consultancy Limited

(Registration number: 07194168)
Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

5

6,884

37

Current assets

 

Cash at bank and in hand

 

46,281

36,756

Creditors: Amounts falling due within one year

6

(4,329)

(5,397)

Net current assets

 

41,952

31,359

Net assets

 

48,836

31,396

Capital and reserves

 

Called up share capital

3

3

Profit and loss account

48,833

31,393

Total equity

 

48,836

31,396

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 13 June 2024 and signed on its behalf by:
 

.........................................
Dr I Salam
Director

   
     
 

Dr Salam Consultancy Limited

Notes to the Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
37 Roper Crescent
Sunbury-on-Thames
TW16 5BA

These financial statements were authorised for issue by the Board on 13 June 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Dr Salam Consultancy Limited

Notes to the Financial Statements for the Year Ended 31 March 2024

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office Equipment

25% Straight Line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

4

Profit before tax

Arrived at after charging/(crediting)

2024
£

2023
£

Depreciation expense

1,652

90

 

Dr Salam Consultancy Limited

Notes to the Financial Statements for the Year Ended 31 March 2024

5

Tangible assets

Office equipment
£

Total
£

Cost or valuation

At 1 April 2023

3,422

3,422

Additions

8,499

8,499

Disposals

(1,092)

(1,092)

At 31 March 2024

10,829

10,829

Depreciation

At 1 April 2023

3,385

3,385

Charge for the year

1,652

1,652

Eliminated on disposal

(1,092)

(1,092)

At 31 March 2024

3,945

3,945

Carrying amount

At 31 March 2024

6,884

6,884

At 31 March 2023

37

37

6

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Directors' loan account

8

499

405

Corporation tax liability

 

2,954

4,157

Other creditors

 

876

835

 

4,329

5,397

7

Share capital

Allotted, called up and fully paid shares

 

Dr Salam Consultancy Limited

Notes to the Financial Statements for the Year Ended 31 March 2024

 

2024

2023

 

No.

£

No.

£

Ordinary Shares of £1 each

2

2

2

2

Ordinary 'A' Shares of £1 each

1

1

1

1

 

3

3

3

3

8

Related party transactions

Transactions with directors

2024

At 1 April 2023
£

Advances to director
£

Repayments by director
£

At 31 March 2024
£

Dr I Salam

Interest free loan repayable on demand

(405)

8,275

(8,177)

(307)

         
       

 

2023

At 1 April 2022
£

Advances to director
£

Repayments by director
£

At 31 March 2023
£

Dr I Salam

Interest free loan repayable on demand

(2,026)

9,077

(7,456)

(405)